HomeInsightsStock Comparison

Accretion Pharmaceuticals Ltd vs Vista Pharmaceuticals Ltd Stock Comparison

Accretion Pharmaceuticals Ltd vs Vista Pharmaceuticals Ltd Stock Comparison

Last Updated on: Jun 13, 2025

Key Highlights

  • The Latest Trading Price of Accretion Pharmaceuticals Ltd is ₹ 78.4 as of 13 Jun 15:30.
  • The P/E Ratio of Accretion Pharmaceuticals Ltd changed from 0 on March 2020 to 0 on March 2024 . This represents a CAGR of 0.0% over 5 yearsThe P/E Ratio of Vista Pharmaceuticals Ltd changed from 0 on March 2020 to 0 on March 2024 . This represents a CAGR of 0.0% over 5 years.
  • The Market Cap of Accretion Pharmaceuticals Ltd changed from ₹ 0 crore on March 2020 to ₹ 0 crore on March 2024 . This represents a CAGR of 0.0% over 5 yearsThe Market Cap of Vista Pharmaceuticals Ltd changed from ₹ 16.09 crore on March 2020 to ₹ 41.38 crore on March 2024 . This represents a CAGR of 20.79% over 5 years.
  • The revenue of Accretion Pharmaceuticals Ltd for the Mar '25 is ₹ 0 crore as compare to the Dec '24 revenue of ₹ 0 crore. This represent the decline of 0% The revenue of Vista Pharmaceuticals Ltd for the Mar '25 is ₹ 3.47 crore as compare to the Dec '24 revenue of ₹ 2.68 crore. This represent the growth of 29.48%.
  • The ebitda of Accretion Pharmaceuticals Ltd for the Mar '25 is ₹ 0 crore as compare to the Dec '24 ebitda of ₹ 0 crore. This represent the decline of 0% The ebitda of Vista Pharmaceuticals Ltd for the Mar '25 is ₹ -0.67 crore as compare to the Dec '24 ebitda of ₹ -1.39 crore. This represent the decline of -51.8%.
  • The net profit of Accretion Pharmaceuticals Ltd changed from ₹ 0 crore to ₹ 0 crore over 8 quarters. This represents a CAGR of 0.0% The net profit of Vista Pharmaceuticals Ltd changed from ₹ -0.95 crore to ₹ -1.5 crore over 8 quarters. This represents a CAGR of 25.66% .
  • The Dividend Payout of Accretion Pharmaceuticals Ltd changed from 0 % on March 2020 to 0 % on March 2024 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Vista Pharmaceuticals Ltd changed from 0 % on March 2020 to 0 % on March 2024 . This represents a CAGR of 0.0% over 5 years.

Share Price

* All values are in Rupees

P/E Ratio Over Time

No data available

Market Cap Over Time

No data available

* All values are in crore

Historical Share Prices

* All values are in Rupees

Revenue Over Time

No data available

* All values are in crore

EBITDA Over Time

No data available

* All values are in crore

Net Profit Over Time

No data available

* All values are in crore

Dividend Payout Over Time

No data available

* All values are in %

About Accretion Pharmaceuticals Ltd

  • Accretion Pharmaceuticals was incorporated in year 2012, the Promoters Mr. Harshad Nanubhai Rathod, Mr. Vivek Ashok Kumar Patel, Mr. Mayur Popatlal Sojitra and Mr. Hardik Mukundbhai Prajapati, came together to establish a pharmaceutical manufacturing unit, to provide health care products.
  • Thus, the foundation of 'Accretion Pharmaceuticals' was laid down, which was started as a Partnership Firm in the name of 'M/s Accretion Pharmaceuticals', pursuant to a deed of partnership dated December 18, 2012. The manufacturing facility which is currently located at Ahmedabad, in Sanand District of Gujarat, commenced its manufacturing operations in year 2014.
  • Thereafter, the Partnership Firm was converted into a Limited Company in the name of 'Accretion Pharmaceuticals Limited' and a certificate of incorporation dated November 29, 2023 was issued by the Registrar of Companies, Central Registration Centre, for and on behalf of the jurisdictional Registrar of Companies.

About Vista Pharmaceuticals Ltd

  • Vista Pharmaceuticals Limited was incorporated on January 25,1991 with the Registrar of Companies, Andhra Pradesh & has obtained Certificate of Commencement of Business on February 7, 1991.
  • The Company is engaged in the formulation of pharmaceutical products.
  • It offers a range of products mainly into the therapeutic areas of gastrointestinal, pain management and anti-infection, catering to common ailments.
  • This division is a primary contributor to the domestic sales of Torrent Pharmaceuticals Ltd., based in Hyderabad, India. The Company was in process of setting up a 100% EOU for manufacture of drug formulations with an installed capacity of 400 million tablets & 200 million capsules per annum.
  • Apart from these, the Company offers over the counter & prescription generic drug products consisting of tablets, capsules and liquids covering various therapeutic categories.

Accretion Pharmaceuticals Ltd News Hub

News

Accretion Pharmaceuticals to discuss results

Accretion Pharmaceuticals will hold a meeting of the Board of Directors of the Company on ...

Read more

05 Jun 2025 10:16

News

NSE SME Accretion Pharma stumbles on market debut

The scrip was listed at 79, a discount of 21.78% over the initial public offer (IPO) price...

Read more

21 May 2025 10:38

News

NSE SME Accretion Pharmaceuticals' IPO ends with subscription of 7.31 times

The initial public offer (IPO) of Accretion Pharmaceuticals received bids for 2,00,06,400 ...

Read more

19 May 2025 11:43

Vista Pharmaceuticals Ltd News Hub

News

Vista Pharmaceuticals to discuss results

Vista Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 30 M...

Read more

21 May 2025 18:20

News

Vista Pharmaceuticals schedules EGM

Vista Pharmaceuticals announced that an Extra Ordinary General Meeting (EGM) of the Compan...

Read more

20 Feb 2025 21:04

News

Vista Pharmaceuticals to convene board meeting

Vista Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 19 F...

Read more

14 Feb 2025 16:40

News

Vista Pharmaceuticals to table results

Vista Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 12 F...

Read more

04 Feb 2025 15:20

News

Vista Pharmaceuticals to convene board meeting

Vista Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 13 N...

Read more

08 Nov 2024 15:20

News

Vista Pharmaceuticals to conduct AGM

Vista Pharmaceuticals announced that the 33th Annual General Meeting (AGM) of the company ...

Read more

10 Sep 2024 10:41

SWOT Analysis Of Vista Pharmaceuticals Ltd

Strength

0

S

Weakness

1

W

Opportunity

0

O

Threats

0

T

BlinkX Score for Vista Pharmaceuticals Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

FAQs for the comparison of null and Vista Pharmaceuticals Ltd

Which company has a larger market capitalization, Accretion Pharmaceuticals Ltd or Vista Pharmaceuticals Ltd?

Market cap of Accretion Pharmaceuticals Ltd is 87 Cr while Market cap of Vista Pharmaceuticals Ltd is 70 Cr

What are the key factors driving the stock performance of Accretion Pharmaceuticals Ltd and Vista Pharmaceuticals Ltd?

The stock performance of Accretion Pharmaceuticals Ltd and Vista Pharmaceuticals Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Accretion Pharmaceuticals Ltd and Vista Pharmaceuticals Ltd?

As of June 13, 2025, the Accretion Pharmaceuticals Ltd stock price is INR ₹78.4. On the other hand, Vista Pharmaceuticals Ltd stock price is INR ₹11.44.

How do dividend payouts of Accretion Pharmaceuticals Ltd and Vista Pharmaceuticals Ltd compare?

To compare the dividend payouts of Accretion Pharmaceuticals Ltd and Vista Pharmaceuticals Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions